Prognostic significance of positive lymph node number in early cervical cancer.

The aim of the present study was to investigate whether the number of metastatic lymph nodes (LNs) is an independent prognostic factor for early cervical cancer. The medical records of 163 stage IB-IIA cervical cancer patients, treated with radical hysterectomy with accompanying pelvic and/or para-aortic lymphadenectomy between 1999 and 2007, were retrospectively reviewed. All prognostic factors identified as being significant in the univariate analysis were included in the multivariate analysis using the Cox proportional hazards model. Of the 156 patients included in our analysis, 27 had LN metastasis, of whom 14 patients had 1 positive node and 13 patients had ≥2 positive nodes. The 5-year overall survival (OS) and progression-free survival (PFS) rates were 92.9 and 87.2%, respectively. In terms of OS, tumour stage (P=0.002) and the number of positive LNs (P=0.021) were identified as significant prognostic factors. In terms of PFS, tumour stage (P=0.049) was identified as a significant prognostic factor. In conclusion, the number of LN metastases is an independent risk factor for poorer survival outcomes in patients with cervical cancer.

[1]  Young Tae Kim,et al.  Asian society of gynecologic oncology workshop 2010. , 2010, Journal of gynecologic oncology.

[2]  A. Jemal,et al.  The global burden of cancer: priorities for prevention , 2009, Carcinogenesis.

[3]  S. Pecorelli.  Corrigendum to “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium” , 2010 .

[4]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  P. Maisonneuve,et al.  Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  G. Kim,et al.  Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma , 2004, International Journal of Clinical Oncology.

[7]  Paul Symonds,et al.  Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis , 2001, The Lancet.

[8]  J. Itami,et al.  Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. , 2000, Anticancer research.

[9]  Kenichi Tanaka,et al.  High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. , 2000, Gynecologic oncology.

[10]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Sakuragi,et al.  Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.

[12]  M. Janicek,et al.  Close vaginal margins as a prognostic factor after radical hysterectomy. , 1998, Gynecologic oncology.

[13]  D A Bloch,et al.  Surgically defined prognostic parameters in patients with early cervical carcinoma: A multivariate survival tree analysis , 1996, Cancer.

[14]  S. Chambers,et al.  Parametrial Involvement, Regardless of Nodal Status: A Poor Prognostic Factor for Cervical Cancer , 1996, Obstetrics and gynecology.

[15]  G. Omura.  Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. , 1996, Journal of the National Cancer Institute. Monographs.

[16]  S. Hsueh,et al.  Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. , 1993, Gynecologic oncology.

[17]  H. Nakano,et al.  Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy , 1992, Cancer.

[18]  B. Sevin,et al.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. , 1990, Gynecologic oncology.

[19]  T. Inoue,et al.  The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB , 1990, Cancer.

[20]  P. Disaia,et al.  A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. , 1989, Gynecologic oncology.

[21]  M. Rotman,et al.  Vascular invasion in stage I carcinoma of the cervix , 1984, Cancer.

[22]  M. Piver,et al.  Prognostic Significance of Cervical Lesion Size and Pelvic Node Metastases in Cervical Carcinoma , 1975, Obstetrics and gynecology.